COVID-19 linear DNA Vaccine -5 / Takis, Applied DNA Sciences - LARVOL DELTA

Applied DNA and Takis Biotech expand Covid-19 vaccine development program to include 5th candidate (Businesswire) - "Applied DNA Sciences Inc....today announce an expansion of their COVID-19 vaccine development program to include a fifth vaccine candidate. Production of all vaccine candidates is expected to be completed this month at Applied DNA’s LinearDNA™ production facility in Stony Brook, N.Y. All vaccine candidates have also been approved by Italy’s Ministry of Health for preclinical animal testing that is scheduled to begin in late April 2020." "

European regulatory • New molecule • Preclinical